Amdocs Limited (NASDAQ:DOX) has been assigned a consensus recommendation of “Hold” from the six analysts that are currently covering the company, Marketbeat reports. Three investment analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average 12 month price target among brokers that have updated their coverage on the stock in the last year is $71.33.
Several research analysts have commented on the stock. BidaskClub cut shares of Amdocs from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, October 15th. Stifel Nicolaus raised their price target on shares of Amdocs from $70.00 to $75.00 and gave the company a “buy” rating in a research note on Friday, November 15th. Finally, JPMorgan Chase & Co. cut their price target on Amdocs from $75.00 to $72.00 and set a “neutral” rating on the stock in a report on Wednesday, November 13th.
Shares of DOX traded down $0.43 during midday trading on Friday, hitting $68.43. 535,700 shares of the stock traded hands, compared to its average volume of 837,331. Amdocs has a 1-year low of $52.60 and a 1-year high of $69.50. The firm has a market capitalization of $9.59 billion, a PE ratio of 16.81, a price-to-earnings-growth ratio of 1.90 and a beta of 0.39. The business’s 50 day moving average price is $66.34 and its two-hundred day moving average price is $63.45.
The firm also recently declared a quarterly dividend, which will be paid on Friday, January 24th. Shareholders of record on Tuesday, December 31st will be given a dividend of $0.285 per share. The ex-dividend date of this dividend is Monday, December 30th. This represents a $1.14 dividend on an annualized basis and a yield of 1.67%. Amdocs’s dividend payout ratio (DPR) is presently 28.01%.
Large investors have recently added to or reduced their stakes in the company. Mitsubishi UFJ Securities Holdings Co. Ltd. bought a new stake in shares of Amdocs during the second quarter valued at about $47,000. Morgan Dempsey Capital Management LLC raised its position in shares of Amdocs by 110.0% during the 2nd quarter. Morgan Dempsey Capital Management LLC now owns 905 shares of the technology company’s stock worth $56,000 after buying an additional 474 shares in the last quarter. Steward Partners Investment Advisory LLC bought a new stake in shares of Amdocs during the 2nd quarter worth about $60,000. Tower Research Capital LLC TRC raised its position in shares of Amdocs by 20.6% during the 3rd quarter. Tower Research Capital LLC TRC now owns 1,000 shares of the technology company’s stock worth $66,000 after buying an additional 171 shares in the last quarter. Finally, CENTRAL TRUST Co lifted its stake in shares of Amdocs by 56.2% in the 2nd quarter. CENTRAL TRUST Co now owns 1,098 shares of the technology company’s stock worth $69,000 after acquiring an additional 395 shares during the period. 91.03% of the stock is owned by institutional investors.
Amdocs Limited, through its subsidiaries, provides software and services to the communications, pay TV, entertainment, and media industry service providers worldwide. The company offers amdocsONE a line of services designed for various stages of a service provider's lifecycle, including planning, delivery, implementation, and ongoing support, as well as consumer experience and monetization, media and digital, enterprise and connected society, service-driven network, and services and agile operation solutions.
Further Reading: What is the Dividend Aristocrat Index?
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.